You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Abbott Laboratories is a global healthcare company that develops, manufactures and markets products across four main segments: medical devices, diagnostic systems, nutritional products and established pharmaceuticals, including branded generics. Its device portfolio features cardiovascular and electrophysiology technologies, structural‑heart and neuromodulation tools, while its diagnostics business offers laboratory and point‑of‑care testing platforms and the widely used FreeStyle Libre continuous glucose monitoring system. In nutrition, Abbott provides well‑known brands such as Similac infant formula and Ensure adult supplements, and its pharmaceutical segment focuses on affordable medicines in emerging markets. Operating in the broader healthcare sector, the company is recognized as a market leader in diabetes care, cardiovascular devices and diagnostic testing, with a diversified business model and a presence in more than 160 countries.
Quarterly Earnings
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q3 FY26 | Oct 15, 2026 (est.) | — |
| Q2 FY26 | Jul 16, 2026 | $1.31 |
| Q1 FY26 | Apr 16, 2026 | $1.15 |
| Q4 FY25 | Jan 22, 2026 | $1.50 |
| Q3 FY25 | Oct 15, 2025 | $1.30 |
Stay ahead of ABT earnings
Get reminders ahead of ABT's next earnings report, so you always know when results are coming.